Quest Diagnostics (DGX) Tops Q3 EPS by 58c, Raises FY Guidance

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $4.31, $0.58 better than the analyst estimate of $3.73. Revenue for the quarter came in at $2.79 billion versus the consensus estimate of $2.73 billion.

GUIDANCE:

Quest Diagnostics sees FY2020 EPS of $9.00-$10.00, versus the consensus of $8.71. Quest Diagnostics sees FY2020 revenue of $8.8-9.1 billion, versus the consensus of $8.74 billion.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
• Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance